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to aid decision making regarding management, ventdcular assist settings/termination of 
assist. All patients were heart failure patients who had undergone LVAD, BiVAD insertion 
+ concomitant procedures including multiple bypass, grafting, and/or atrioventricular 
valve repair. The SEE tube placed on the anterior RV surface provided optimal windows 
for imaging of RV and LV function as well as color Doppler visualization of valvular regur- 
gitation. Results: All patients tolerated SEE with no alteration of vital signs, and there 
were no complications despite multiple TEE probe introductions; quantitative and qualita- 
tive observations precluded the need for other imaging procedures and assisted VAD 
management. 
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1085-131 Eva luat ion  of  the  Newly Designed Aortic Root 
Prosthesis and the  Role of  Leaf let  Repair  in the  Valve 
Sparing Operat ion  
Mano J. Thubdkar. Kenton J. Zehr, Francis Robicsek, Eric Skipper, Geoffrey Gong, Bratt 
L. Fowler, Heineman Medical Research Laboratory, Carolinas Medical Center, Charlotte, 
North Carolina, Mayo Clinic, Rochester, Minnesota. 
Introduction: A newly designed aortic root prosthesis with compliant sinuses was evalu- 
ated and the role of leaflet repair was studied in the valve sparing operation. 
Methods: In vitro, 8 aortic root prostheses were sewn to 8 normal (human) aortic valves 
and studied in a left heart simulator. In 7 patients, with annuloaortic ectasia and mild to 
severe AI, the aortic root was reconstructed with the prosthesis and the valve was spared 
while on cerdio-pulmonary bypass. The sinus height (Hs), and the valve diameter at the 
sinotubular junction (ST J-D) were measured from patients' TEE. Also, after the aorta and 
the sinuses were excised during surgery, the valve size at the sinotubular junction was 
measured while moving the commissures centrally till adequate leaflet coaptation was 
achieved, and then compared with the "normal" valve size in an adult of similar height 
and weight. 
Results: In vitro, all of the valves spared, using the newly designed aortic root prosthe- 
sis, showed the normal dynamics with no AI. In contrast, in three patients the leaflet free- 
edge had to be shortened to reduce the AI. None of the patients' valves showed com- 
plete competence. Four patients had trace AI and 3 had mild AI. In the normal intact 
valve the ratio Hs/STJ-D was 0.8 - I, in the dilated aortic root it was 0.5 - 0.7, and after 
the valve sparing it was restored to 0.8 - 1. In the patients, the valve size after the aortic 
root excision was 3 - 6 mm larger than that in a similar size adult, indicating that the leaf- 
lets were stretched. 
Conclualona: In the valve sparing operation, one may encounter both the dilated aodic 
root and stretched leaflets. Replacing only the aortic root with a prosthesis will reduce AI, 
but for complete valvular competence shortening of the leaflet free edge may be 
required. The newly designed aortic root prosthesis appears to function well in this proce- 
dure. 
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1085-132 Lipide in Pat ients  With Aor t i c  Valve Replacement: 
Impact of Preoperative Cholesterol and Triglyceride 
Levels  on  the  Degenerat ion  o f  Per icardial  Valve 
Proethesee 
Geore Nollert. Jessica Miksch, Bruno Reichart, Department of Cardiac Surge~ 
University of Munich, Munich, Germany. 
Background: Recent studies demonstrated the influence of cholesterol on the progres- 
sion of aortic stenosis. We hypothesised that high lipid levels may also stimulate the 
degeneration of pericardial heart valves and lead to reoberation due to structural valve 
failure especially in younger patients with high degeneration rates. 
Methods: In 1984 and 1985 246 patients received pericardial aortic heart valves (61% 
male, age 56±11 years) and had preoperative lipid investigations at our institution. These 
patients received a Hancock Extracorporeal valve (HE; n=177) or a Carpantier Edwards 
pericardial valve (CEP; n=4) in aortic or mitral (HE n= 63; CEP n= 30) position. Double 
valve replacement was performed in 29 patients. 
Results: Operative, 1, 5, 10, and 15 years actuarial survival was 90%, 84%, 66%, 48%, 
and 41% respectively. Freedom from reoperation at 5, 10, and 15 years was 75%, 25%, 
and 11%. Patients younger than 60 years who had to be reoperatad within 10 years had 
higher preoperative cholesterol (235 ± 59rag/all vs. 194±39mg/gl; p=0.05) and tdglycedde 
levels (143 ± 61 mg/dl vs. 95 ± 32mg/dl; p=0.035) than those reoperatad after 10 years. 
In order to calculate the influence of preoperative lipid levels on the degeneration rate 
patients were split into quartiles. Patients below 60 years of the lowest and highest cho- 
lesterol quartiles were free of reoperation in 83% vs. 65 %, 40% vs. 0%, and 11% vs.0% 
(p=0.008) at 5, 10, and 15 years. The figures for the lower and higher triglycedde halves 
were 76% vs. 71%, 36% vs. 8%, and 11% vs. 0% (p=0.015). The differences were similar 
for young patients after solitary aortic valve replacement (cholesterol p=0.0019; triglycer- 
ida p=0.08). However, in this subgroup older patients with low cholesterol levels had 
more reoperations than those with high levels (p=0.045). Survival was independent from 
cholesterol levels, but high triglyceride values (>170 rag/all) were related to worse out- 
come (p=0.004). 
Conclusions: Preoperative cholesterol and triglyceride levels are predictors of structural 
valve failure of pericardial valves. Lowedng of triglyceride and cholesterol levels may be 
a new concept to reduce degeneration of pericardial valves in patients younger than 60 
years. 
1 085-133 Outcomes 15 Years After  Valve Rep lacement  With a 
Mechanical Versus Bioproethetic Valve in Patients 
Between 60 and 70 Years of Age 
G. Hanania, P. M. Michel, J. M. Montely, H. Warembourg, O. Nardi, On Behalf of the 
Working Group of Vaivulopathy TheFrench Society of Cardiology, Hopita/Robert 
Ba/langer, Aulnay-sous bois. 
Background: The choice between mechanical prosthesis (MP) and biopresthesis (BP) 
between 60 and 70 years of age remains controversial Methods: in order to document 
this choice a cooperative and retrospective study analyses the outcome of 441 patients 
operated on in 1985. Results: The valvulopathy was aortic, mitral and mitroaortic in 
respectively 244, 134 and 63 patients. MP and BP were implanted respectively 228 
(52%) and 204 (46%) patients; 9 mitroaortic (2%) had both a BP and a MP. The operative 
mortality (27 cases) was 6.1% lower for aortic patients (3.5%) than for mitrel (7%) and 
bivalvular (13%) patients. On follow-up 244 patients (55%) died. The 15 years actuarial 
survival rates are not different for mitral disease between BP (31%) and MP (25%) (ns). It 
is better for aortic MP (47%) than for BP (26%) (p<0.001). The valve related mortality is 
higher for mitrsl valve (MP 28%, BP 25%) than for aortic (MP 17%, BP 16%). The non 
cardiac mortality is higher than the valve related mortality in every group except for mitral 
BP. Primary valve failure occurs for 8% of aortic BP versus 30% of mitral BP. Valve 
related complications concern 22% of aortic BP, 26% of aortic MP, 32% of mitral MP and 
59% of mitral BP. Among the monovaluvular diseases, 15 years actuarial survival rates is 
respectively 47% for women and 34% for men. Conclualon: These results contra indi- 
cate the use of mitral BP before 70 years. For aortic diseases the rate of primary valve 
failure is actually low at 15 years after surgery. Nevertheless in the cohort, half of the 
women and a third of men have reached or have turned eighty. So it seems more advis- 
able to prefer MP to BP before seventy to avoid lata re-operations. 
1085-134 Elevated B-'~Jpe Natrlureti¢ Peptide in Patients With 
Aeymptomatic Aortic Regurgitation and Normal Left  
Ventr icu lar  Systo l i c  Function 
Micah J. Elmer. Deborah Ekery, Vera Rigolin, Maryl Johnson, Mihai Gheorghiade, Robert 
Bonow, William G. Cotfs, Northwestern University Medical School, Chicago, Illinois. 
Background: Chronic aortic regurgitation (AR) imposes a progressive hemodynamic bur- 
den upon the left ventricle (LV). Management is based on symptoms and LV size and 
function. To determine if B-Tybe natduretic beptide (BNP), a hormone secreted by ven- 
tdcular myocytas under strain, may play a role in decision making for patients with AR, 
we measured BNP levels in patients with chronic asymptomatic AR and normal LV sys- 
tolic function. 
Methods: Ten asymptomatic male patients with isolated AR, age 31-70y (48.5 +/- 14.7), 
underwent echocardiography and measurement of serum BNP levels. Standard echcoar- 
diographic parameters were recorded and AR was quantified by the ratio of jet height 
(JH) to LV outflow tract (LVOT) in the parasternal long axis view. Four males age 29-54y 
(40.25 +/- 11.7) with normal echocardiograms sewed as controls. 
Results: There was no significant difference in age or ejection fraction between patients 
and controls. The mean BNP level was neady fourfold higher in patients with AR com- 
pared to controls (23.7 +/- 23.1 vs 6.1 +/- 4.2pg/ml p=.04). Using linear regression analy- 
sis, significant (p<.05) univariats predictors of BNP in patients with AR include: LV mass 
index(r=.75), LV end diastolic volume (r=.68), LV end systolic volume (r=.59), LV end 
